ADHD Medication Manufacturing in the US - Industry Market Research Report
Description
ADHD Medication Manufacturing
The ADHD Medication Manufacturing industry has exhibited steady growth over the five years to 2019, driven by the continued growth in the incidence of ADHD. However, revenue growth has slowed significantly compared with its extreme growth in the late 2000s. This can partially be attributed to expiring patents and increased competition from generic drugs, creating downward pressure on prices and restricting industry profit. However, total health expenditure is forecast to increase more quickly over the next five years as insurance coverage improves. The adult market will continue to grow as adult usage of ADHD medications increases. Additionally, the number of children aged 9 and younger is forecast to increase, bolstering the number of ADHD diagnoses, as ADHD is typically first diagnosed in young children.
Operators in this industry manufacture medications that treat people with attention deficits, such as attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD).
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
The ADHD Medication Manufacturing industry has exhibited steady growth over the five years to 2019, driven by the continued growth in the incidence of ADHD. However, revenue growth has slowed significantly compared with its extreme growth in the late 2000s. This can partially be attributed to expiring patents and increased competition from generic drugs, creating downward pressure on prices and restricting industry profit. However, total health expenditure is forecast to increase more quickly over the next five years as insurance coverage improves. The adult market will continue to grow as adult usage of ADHD medications increases. Additionally, the number of children aged 9 and younger is forecast to increase, bolstering the number of ADHD diagnoses, as ADHD is typically first diagnosed in young children.
Operators in this industry manufacture medications that treat people with attention deficits, such as attention deficit disorder (ADD) and attention deficit hyperactivity disorder (ADHD).
This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.
Table of Contents
44 Pages
- TABLE OF CONTENTS
ABOUT THIS INDUSTRY
Industry Definition
Main Activities
Similar Industries
Additional Resources
INDUSTRY AT A GLANCE
INDUSTRY PERFORMANCE
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
PRODUCTS & MARKETS
Supply Chain
Products & Services
Demand Determinants
Major Markets
International Trade
Business Locations
COMPETITIVE LANDSCAPE
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Basis of Competition
Barriers to Entry
Industry Globalization
MAJOR COMPANIES
OPERATING CONDITIONS
Capital Intensity
Technology & Systems
Revenue Volatility
Regulation & Policy
Industry Assistance
KEY STATISTICS
Industry Data
Annual Change
Key Ratios
JARGON & GLOSSARY
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
